PM6582V0 Glutamax advanced sestino lancio sospensione 2026

Bibliografia

1.    AA. VV. Glutathione, reduced (GSH). Monograph. Alt Med Rev 2001;6(6):601-607
2.    Barry-Heffernan C, et al. Biomarkers of oxidative stress  as an assessment of the redox status of the liver in dogs. J Vet Intern Med 2019;33:611-617
3.    Biasibetti E, et al. Effect of Glutamax® Forte, a multicomponent dietary supplement containing Silibinin-phosphatidylcholine complex, in cats with liver disease. SEJ Life Science 2018;1(1):1-12
4.    Bloom A, et al. Zinc supplementation and its benefits in the management of chronic liver disease: anin-depth literature review. Annals of Hepatology 2021; https://doi.org/10.1016/j.aohep.2021.100549
5.    Cacciatore I, et al. Prodrug approach for increasing cellular glutathione levels. Molecules 2010;15:1242-1264
6.    Center SA, et al. Liver glutathione concentration in dogs and cats with natural occurring liver disease. Am J Vet Res 2002;63:1187-1197
7.    Center SA. Antioxidant in liver disease: a focus on thiol supplementation. WSAVA 2006 World Congress Proceedings:423-426
8.    Center SA. Standard care in chronic hepatitis. WSAVA 2006 World Congress Proceedings: 43-49
9.    Dei Cas M, et al. Dietary curcumin: Correlation between bioavailability and health potential. Nutrients 2019, 11, 2147; doi:10.3390/nu11092147
10.    Di Paola R, et al. S-acetyl-glutathione attenuates carbon tetrachloride-induced liver injury by moduating oxidative imbalance and oxidation. Int J Mol Sci 2022,23:4429
11.    Fanelli S, et al. Oral administration of S-acetyl-glutathione: impact on the levels of glutathione in plasma and heritrocytes of healthy volunteers. Int J Clin Nutr Diet 2018;4:134
12.    Filburn CR, et al. Bioavailability of a silybin-phosphatidylcholine complex in dogs. J Vet Pharmacol Ther. 2007;30:132-138
13.    Gupta SC, et al. Multitargeting by turmeric, the golden spice: from kitchen to clinic. Mol Nutr food Res 2013;57:1510-1528
14.    Hu RW, et al. Curcumin in hepatobiliary disease: pharmacotherapeutic properties and emerging potential clinical applications. Annals of Hepatology 2017;16(6):835-841
15.    Kendall A, et al. Glutathione peroxidase activity, plasma total antioxidant activity, and urinary F2-isoprostanes as a marker of oxidative stress in anemic dogs. J Vet Intern Med 2017,31:1700-1707
16.    Kidd PM, et al. A review of the bioavailability and clinical efficacy of milk thistle phytosome: a silybin-phosphatidylcholine complex (Siliphos). Altern Med Rev 2005;10(3):193-203
17.    Kidd PM, et al. Bioavailability and activity of phytosome complexes from botanical poliphenols: the silymarin, curcumin, green tea and grape seed extracts. Alternative Medicine Review2009;14:3
18.    Kretszchmar M. Regulation of hepatic glutathione  metabolism and its role in hepatotoxicity. Exp Toxic Pathol 1996;48:439-446
19.    Kunnumakkara AB, et al. Curcumin, the golden nutraceutical: multitargeting for multiole chronic disease. British Journal of Pharmacology 2017;174:1325-1348
20.    Indena. Siliphos technical sheet 10/2014
21.    Leonel C, et al. Expression of glutathione, glutathione peroxidase and glutathione S-transferase pi in canine mammary tumors. BMC Veterinary Research 2014;10:49
22.    Locigno R, et al. S-acetyl-glutathione selectively induces apoptosis in human lymphoma cells thorough a GSH-independent mechanism. International Journal of Oncology 2002;20:69-75
23.    Lubos E, et al. Glutathione-peroxidase 1 in health and disease: from molecular mechanisms to therapeutic opportunity. Antioxid Redox Signal 2011;15:1957-1997
24.    Martello e, et al. Antioxidant effect of a dietary supplement containing fermentative S-acetyl-glutathione and sylibin in dogs with liver disease. Vet Sci 2023;10:131
25.    Meyer HP, et al. Hepatobiliary disease. In Tatcher CD, Hand MH, Remillard RL. Small Animal Clinical Nutrition Vth edition 2010 Mark Morris Institute.
26.    Mohommad MK, et al. Zinc and liver disease. Nutr Clin Pract. 2012 February ; 27(1): 8–20. doi:10.1177/0884533611433534
27.    Okun JG, et al. S-acetylglutathione normalizes intracellular glutathione content in cultured fibroblast from patient with glutathione synthetase deficiency. J Inherit Metab Dis 2004;27:783-786
28.    Pennickx MJ. An overview on glutathione in Saccharomyces versus non conventional yeasts. FEMS Yeast Research 2002;2:295-305
29.    Perondi F, et al. The effect of a diet supplement containing -acetyl-glutathione (SAG) and other antioxidant natural ingredients on glutathione peroxidase in healthy dogs: a pilot study. Italian Journal of Animal Science, 22:1, 589-593, DOI: 10.1080/1828051X.2023.2221073
30.    Sartor LL, et al. Terapia farmacologica razione delle affezioni epato-biliari del cane e del gatto. Veterinaria 2004:18(4)
31.    Scanlan N. Compromised hepatic detoxification in companion animals and its correction via nutritional supplementation and modified fasting. Altern Med Rev 2001;6(suppl):24-37
32.    Spee B, et al. Copper metabolism and oxidative stress in chronic inflammatory and cholestatic liver disease. J Vet Intern Med 2006;20:1085-1092
33.    Suntar I, et al. An overview on Citrum aurantium L: its function as food ingredient and therapeutic agent. Oxidative Medicine and Cellular Longevity 2018; https://doi.org/10.1155/2018/7864269
34.    Tang L, et al.  Three-pathway combination for glutathione biosynthesis in Saccharomyces cerevisiae. Microb Cell Fact 2015;14:139
35.    Twedt DC. Therapeutic use of  cytoprotective agents in canine and feline hepatobiliry disease. Atti 67° Congresso Nazionale SCIVAC 2010
36.    Twedt DC. Hydiopatic hepatitis and chirrosis in dogs. 67° SCIVAC National Congress 2010:135-140
37.    Twedt DC. The latest update on feline liver disease. NAVC Conference 2009 Proceedings:550-552
38.    Twedt DC. Update on feline hepatobiliary disease. 67° SCIVAC National Congress 2010:20-126
39.    Viviano KR, et al. Glutathione, cysteine and ascorbate concentration in clinically ill dogs and cats. J Vet Intern Med 2009;23:250-257
40.    Webb CB et al. Assessment of oxidative stress in leukocyte and granulocyte function following oral administration of a silibinin-phosphatidylcholine complex in cats. Am J Vet Res 2009;70:57-62
41.    Webster CRL, et al. ACVIM consensus statement on the diagnosis and treatment of chronic hepatitis in dogs. J Vet Intern Med. 2019;33:1173–1200.
42.    Wu G, et al. Glutathione metabolism and its implication for health. J Nutr 2004;134:489-492